Nindhana Paranthaman

Anchor Show/Hide

Anchor_Hide

Nindhana Paranthaman

Executive Medical Director
Summit Therapeutics 

Nindhana Paranthaman is a biotech executive with over a decade of experience in drug development across multiple modalities and indications. She is Executive Medical Director at Summit Therapeutics, leading clinical development strategy for ivonescimab, a first-in-class investigational PD-1/VEGF bispecific antibody. 

Previously, she held leadership roles at Exelixis, Genentech, Amgen, and Bristol-Myers Squibb, contributing to the development and commercialization of therapies for solid tumors and autoimmune diseases. 

Nindhana earned her medical degree from Sri Ramachandra Institute of Higher Education and Research and an MBA from Johns Hopkins University. She is also an active speaker, mentor, and advocate for diversity, equity, and inclusion.